Skip to content

The Effect of using Pneumatic Pump on the Hypotension due to sedation in Patients Admitted to the ICU

The effect of pneumatic pumps on hypotension due to Midazolam and Fentanyl in patients admitted to the ICU

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190225042836N1
Enrollment
56
Registered
2019-04-16
Start date
2019-03-06
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unspecified disorders of the circulatory system. Hypotension due to drugs

Interventions

Intervention 1: Intervention group: In supine mode, on patients that are hospitalized in ICU and receive "Midazolam" and "Fentanyl" according to the specialist's order, Pneumatic pump will be applied

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Hospitalized in ICU under mechanical ventilation Written consent form from patient's relatives (first degree relative) Having order to receive 0.01-0.05 mg/kg "Midazolam" and 5 µg/kg "Fentanyl" 20 percent decrease in non-invasive blood pressure (MAP-SBP) to the initial non-invasive blood pressure No ulcers, skin or vascular effects or fractures in the legs Stable hemodynamics according to the ICU specialists No Cardiovascular failure according to the patients medical history Patients should be 20-80 years old

Exclusion criteria

Exclusion criteria: Making an unstable status while doing treatment Contraindications for "Midazolam" or "Fentanyl" or both of them

Design outcomes

Primary

MeasureTime frame
Non-invasive blood pressure variations. Timepoint: Measuring non-invasive blood pressure before, instantly, 3 and 5 minutes after treatments. Method of measurement: Monitoring device.

Secondary

MeasureTime frame
Heart beat variation. Timepoint: Measuring heart beat before, instantly, 3 and 5 minutes after treatments. Method of measurement: Monitoring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Bagherzadeh Bahabadi

Gonabad University of Medical Sciences

bagherzadeh.a.stu@gmu.ac.ir+98 51 5722 4058

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026